The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Oral minoxidil for the treatment of late alopecia in cancer survivors.
 
Alyce Mei-Shiuan Kuo
No Relationships to Disclose
 
Rachel E. Reingold
No Relationships to Disclose
 
Kwami Ketosugbo
No Relationships to Disclose
 
Alexander Pan
No Relationships to Disclose
 
Stephen W Dusza
No Relationships to Disclose
 
Lukas Kraehenbuehl
No Relationships to Disclose
 
Devika Gajria
No Relationships to Disclose
 
Diana E Lake
No Relationships to Disclose
 
Jacqueline Bromberg
No Relationships to Disclose
 
Shari Beth Goldfarb
Consulting or Advisory Role - Procter & Gamble; Sermonix Pharmaceuticals
Research Funding - Paxman; Sprout Pharmaceuticals
 
Tiffany A. Traina
Consulting or Advisory Role - Agendia; AstraZeneca; Athenex; Ayala Pharmaceuticals; Blueprint Medicines; Daiichi Sankyo; Eisai; Ellipses Pharma; Exact Sciences; Foundation Medicine; Fuji Pharma; Genentech/Roche; Gilead Sciences; Ionis Pharmaceuticals; ITeos Therapeutics; Merck; Pfizer; Puma Biotechnology; Seagen
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Ayala Pharmaceuticals (Inst); Carrick Pharm (Inst); Daiichi Sankyo (Inst); Eisai (Inst); Genentech/Roche (Inst); Immunomedics (Inst); Innocrin Pharma (Inst); Novartis (Inst); Pfizer (Inst)
 
Monica N. Fornier
Honoraria - Eisai
Consulting or Advisory Role - Eisai
 
Ayca Gucalp
Research Funding - BioAtla (Inst); Bristol-Myers Squibb (Inst); Innocrin Pharma (Inst); Merck (Inst); Novartis (Inst); OncoTherapy Science (Inst); Pfizer (Inst); Roche (Inst); Zenith Epigenetics (Inst)
 
Megan Dauscher
No Relationships to Disclose
 
Alina Markova
Consulting or Advisory Role - Alira Health; Janssen
Research Funding - Amryt Pharma (Inst); Incyte (Inst)
 
Mario E. Lacouture
Stock and Other Ownership Interests - Oncoderm (I)
Honoraria - Apricity Health; AstraZeneca; Deciphera; Incyte; Innovaderm; Janssen; L'Oreal; La Roche-Posay; Lutris; MJH Associates; Nanology; Novartis; Novocure; OnQuality Pharmaceuticals; RBC consultants; Relay Therapeutics; Roche/Genentech; Seattle Genetics/Astellas; Tyra Biosciences
Consulting or Advisory Role - Apricity Health; AstraZeneca; Deciphera; Genentech; Incyte; Innovaderm; Janssen Research & Development; La Roche-Posay; Lutris; Novartis; Novocure; OnQuality Pharmaceuticals; Relay Therapeutics; Roche; Roche; Seagen; Tyra Biosciences
Research Funding - AstraZeneca/MedImmune (Inst); Columbia University (Inst); Lutris; National Jewish Health (Inst); Novartis (Inst); Novocure; Paxman; US Biotest
Other Relationship - Oncoderm (I)
(OPTIONAL) Uncompensated Relationships - Oncoderm